CLINICAL_TRIALS
trial_result
· 2017-01-16
Clinical Trial Update: Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy [Phase 1]
Summary
Phase 1 clinical trial evaluating Voluma dermal filler for HIV-associated facial lipoatrophy has completed with results posted in January 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jared Jagdeo, MD, MS | Conditions: HIV Facial Lipoatrophy | Phase 1 | Status: COMPLETED | Results posted: 2017-01-16